Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 293-300

  Lam, Joanna W S ^a   Lui, Simon S Y ^a,b,c   Wang, Ya ^b,c   Chan, Raymond C K ^b,c   Cheung, Eric F C ^a  

^a CASTLE PEAK HOSPITAL   (Hong Kong)

^b INSTITUTE OF PSYCHOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Medication management; Prospective memory; Schizophrenia; Treatment adherence

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LORAZEPAM; NEUROLEPTIC AGENT; TRIHEXYPHENIDYL;

ADULT; AKATHISIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; PARKINSONISM; PATIENT CARE; PATIENT COMPLIANCE; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE MEMORY; RISK FACTOR; SCHIZOPHRENIA; SELF REPORT; SYMPTOM; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MEMORY DISORDERS; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT;

EID: 84878981287     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.010     Document Type: Article

References (47)

1. Altgassen M., Kliegel M., Rendell P., Henry J.D., Zollig J. Prospective memory in schizophrenia: the impact of varying retrospective-memory load. J. Clin. Exp. Neuropsychol. 2008, 30:777-788.
2. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. Am. J. Psychiatry 1993, 150:873-879.
3. Barkhof E., Meijer C.J., de Sonneville L.M.J., Linszen D.H., de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia - a review of the past decade. Eur. Psychiatry 2012, 27:9-18.
4. Barnes T.R.E. A rating scale for drug-induced akathisia. Br. J. Psychiatry 1989, 154:672-676.
5. Buchanan R.W., Keefe R.S.E., Umbricht D., Green M.F., Laughren T., Marder S.R. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5years later?. Schizophr. Bull. 2011, 37(6):1209-1217.
6. Callicott J.H., Ramsey N.F., Tallent K., Bertolino A., Knable M.B., Coppola R., Goldberg T., et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998, 18:186-196.
7. Chan R.C.K., Qing Y., Wu Q., Shum D. Prospective memory in healthy Chinese people: the latent structure of the Comprehensive Assessment of Prospective Memory Questionnaire. Neuropsychol. Rehabil. 2010, 20:459-470.
8. Chouinard G., Margolese H.C. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr. Res. 2005, 76:247-265.
9. Einstein G.O., McDaniel M.A. Normal aging and prospective memory. J. Exp. Psychol. Learn. Mem. Cogn. 1990, 16:717-726.
10. Ellis J.A. Prospective memory or the realization of delayed intentions: a conceptual framework for research. Prospective Memory: Theory and Applications 1996, 1-22. Erlbaum, Mahwah, NJ. M. Brandimonte, G.O. Einstein, M.A. McDaniel (Eds.).
11. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 1997, 23:637-651.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version 1995, Biometrics Research Institute, New York State Psychiatric Institute, New York, NY.
13. Gilmer T.P., Dolder C.R., Lacro J.P., Folsom D.P., Lindamer L., Garcia P., Jeste D.V. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. Am. J. Psychiatry 2004, 161(4):692-699.
14. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch. Gen. Psychiatry 1997, 54:159-165.
15. Gong Y.X. Manual of Wechsler Adult Intelligence Scale - Chinese version 1992, Chinese Map Press, Changsha.
16. Gong Y.X., Gong Y.X., Jiang D.W., Deng J.L., Dai Z.S., Zhou Q.Z. Manual of Wechsler Memory Scale - Chinese Version 1989, Hunan Medical College Press, Changsha.
17. Heinrichs R.W., Goldberg J.O., Miles A.A., McDermid Vaz S. Predictors of medication competence in schizophrenia patients. Psychiatry Res. 2008, 157:47-52.
18. Henry J.D., Crawford J.R. A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 2004, 18:284-295.
19. Hogan T.P., Awad A.G., Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983, 13:177-183.
20. Hung G.B.K. A comparison of two methods for calculating total antipsychotic dose. Hong Kong J. Psychiatry 2007, 17:87-90.
21. Jeste S.D., Patterson T.L., Palmer B.W., Dolder C.R., Goldman S., Jeste D.V. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr. Res. 2003, 63:49-58.
22. Kampman O., Lehtinen K. Compliance in psychoses. Acta Psychiatr. Scand. 1999, 100:167-175.
23. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
24. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 2002, 63:892-909.
25. Lui S.S.Y., Wang Y., Liu A.C.Y., Chui W.W.H., Gong Q.Y., Shum D., Cheung E.F.C., et al. Prospective memory in patients with first-onset schizophrenia and their non-psychotic siblings. Neuropsychologia 2011, 49:2217-2224.
26. McIntosh A., Conlon L., Lawrie S., Stanfield A.C. Compliance therapy for schizophrenia (Review) 2009, The Cochrane Library, (1).
27. Mohamed S., Rosenheck R., McEvoy J., Swartz M., Stroup S., Lieberman J.A. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr. Bull. 2009, 35:336-346.
28. Nelson H.E. A modified card sorting task sensitive to frontal lobe defects. Cortex 1976, 12:313-324.
29. O'Brien R.M. A caution regarding rules of thumb for variance inflation factors. Qual. Quant. 2007, 41:673-690.
30. Patterson T.L., Lacro J., McKibbin C.L., Moscona S., Hughs T., Jeste D.V. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia. J. Clin. Psychopharmacol. 2002, 22:11-19.
31. Ritch J.L., Velligan D.I., Tucker D., Dicocco M., Maples N.J. Prospective memory in schizophrenia. Schizophr. Res. 2003, 60:180.
32. Robertson I.H., Manly T., Andrade J., Baddeley B.T., Yiend J. 'Oops!': Performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 1997, 35:747-758.
33. Shum D., Ungvari G.S., Tang W.K., Leung J.P. Performance of schizophrenia patients on time-, event-, and activity-based prospective memory tasks. Schizophr. Bull. 2004, 30:693-701.
34. Smith J.M., Kucharski L.T., Oswald W.T., Waterman L.J. A systematic investigation of tardive dyskinesia in inpatients. Am. J. Psychiatry 1979, 136:918-922.
35. Staring A.B.P., Van der Gaag M., Duivenvoorden H.J., Weiden P.J., Mulder C.L. Why to patients with schizophrenia who have poor insight stll take antipsychotics? Memory deficits as moderators between adherence belief and behavior. J. Psychiatr. Pract. 2011, 17:320-329.
36. Twamley E.W., Woods S.P., Zurhellen C.H., Vertinski M., Narvaez J.M., Mausbach B.T., et al. Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia. Schizophr. Res. 2008, 106:42-49.
37. Vedhara K., Wadsworth E., Norman P., Searle A., Mitchell J., Macrae N., O'Mahony M., et al. Habitual prospective memory in elderly patients with Type 2 diabetes: implications for medication adherence. Psychol. Health Med. 2004, 9:17-27.
38. Velligan D.I., Lam Y.W., Glahn D.C., Bareet J.A., Maples N.J., Ereshefsky L., Miller A.L. Defining and assessing adherence to oral antipsychotics. A review of the literature. Schizophr. Bull. 2006, 32:724-742.
39. Velligan D.I., Weiden P.J., Sajatovic M., Scott J., Carpenter D., Ross R., Docherty J.P. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J. Psychiatr. Pract. 2010, 16(1):34-45.
40. Wang Y., Chan R.C.K., Yu X., Shi C., Cui J., Deng Y. Prospective memory deficits in subjects with schizophrenia spectrum disorders: a comparison study with schizophrenic subjects, psychometrically defined schizotypal subjects, and healthy controls. Schizophr. Res. 2008, 106:70-80.
41. Wang Y., Cui J., Chan R.C.K., Deng Y., Shi H., Hong X., Li Z., et al. Mata-analysis of prospective memory in schizophrenia: nature, extent, and correlates. Schizophr. Res. 2009, 114:64-70.
42. Woods S.P., Moran L.M., Carey C.L., Dawson M.S., Iudicello J.E., Gibson S., Grant I., et al. Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?. Arch. Clin. Neuropsychol. 2008, 23:257-270.
43. Woods S.P., Dawson M.S., Weber E., Gibson S., Grant I., Atkinson J.H. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J. Int. Neuropsychol. Soc. 2009, 15:42-52.
44. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168:472-485.
45. Xiang Y.T., Shum D., Chiu H.F.K., Tang W.K., Ungvari G.S. Association of demographic characteristics, symptomatology, retrospective and prospective memory, executive functioning and intelligence with social functioning in schizophrenia. Aust. N. Z. J. Psychiatry 2010, 44:1112-1117.
46. Zhou F.C., Xiang Y.T., Wang C.Y., Dickerson F., Au R.W.C., Zhou J.J., Shum D.H.K., et al. Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia. Schizophr. Res. 2012, 135:34-39.
47. Zygmunt A., Olfson M., Boyer C.A., Mechanic D. Interventions to improve medication adherence in schizophrenia. Am. J. Psychiatry 2002, 159:1653-1664.